| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,111Unit of Molecular Toxicology, Institute for Medical Research and Occupational Health, HR-10001 Zagreb, Croatia; 2Department of Physiology and Pathophysiology, Georg-August University of Goettingen, 37073 Goettingen, Germany; and 3Department of Pharmacology and Toxicology, Kyorin University School of Medicine, Tokyo 181-8611, Japan
Submitted 30 January 2004 ; accepted in final form 4 March 2004
 |
ABSTRACT |
|---|
 TOP ABSTRACT MATERIALS AND METHODSRESULTSDISCUSSIONGRANTSREFERENCES |
|---|
kidney; membrane transport; organic anion transporter; progesterone; sex differences; steroid hormones
Previous studies of probenecid-sensitive p-aminohippurate (PAH) secretion have indicated a multispecific transporter, represented by a tertiary active PAH/
-ketoglutarate exchange localized in the proximal tubule cell BLM, as the pivotal mechanism for organic anion secretion in the nephron (29, 39, 45, 46). In the rabbit, tubular secretion of PAH occurs along the entire proximal tubule, with the highest transport activity in the S2 segment (40, 41, 51).
In the mammalian kidney, two multispecific organic anion transporters, OAT1 (Slc22a6) and OAT3 (Slc22a8), which belong to a larger OAT family, have been cloned, immunocytochemically and functionally characterized, and found to transport PAH in addition to a variety of other substrates (36, 42, 48). A third member of this family, OAT2, was also demonstrated in the kidney (21, 37), but its PAH-transporting capability is negligible compared with OAT1 and OAT3, and it is thus assumed to be less important for this process. Although recent data have indicated that OAT1, with its 5–10 times higher affinity for PAH than that of OAT3, may be a major player in the secretion of PAH and some other organic anions in the mammalian kidney (12, 36, 42), the relative importance of both transporters in secretion may be influenced by their expression levels along the nephron.
OAT1 was cloned from rat (38, 43), human (13, 16, 24, 30, 31), and flounder kidneys (50). By Northern blotting, OAT1 mRNA was detected in rat kidney cortex more than in the outer medulla, whereas by in situ hybridization the message was more abundant in deeper parts of the cortex and in medullary rays (38). By immunocytochemistry in the rat kidney, the protein was localized to the BLM of predominantely the S2 proximal tubule segments and less in the S1 and S3 segments (21, 27, 44), and a similar localization was found for human OAT1 (12, 16, 26). OAT3 was originally cloned from the rat brain (22) and was also demonstrated in the rat and human kidney at the level of both mRNA and protein (12, 21, 22, 26). In the human kidney, OAT3 was immunostained in the BLM of the cortical proximal convoluted tubule, where it colocalized with OAT1 (12, 26), whereas in the rat kidney, the transporter was immunolocalized to the BLM along the entire proximal tubule, thick ascending limb of Henle (TALH), connecting segment, and collecting duct (21).
Previous data indicate that the rate of renal organic anion transport is regulated by sex steroids (3, 5, 17, 19, 32). In rats in vivo, the rate of PAH transport in male kidneys was greater than that in female kidneys. PAH uptake studies with kidney cortex slices in vitro showed that 1) uptake in male rats was greater than that in female rats; 2) castration of male rats significantly reduced uptake, whereas ovariectomy of female rats had no major effect; 3) treatment of gonadectomized rats with testosterone, but not with estrogen, stimulated uptake; and 4) gender differences in uptake did not exist in very young rats and appeared after maturation.
Cerutti et al. (11) recently demonstrated gender differences in OAT1 protein abundance in isolated rat renal cortical BLM by immunoblotting. However, at the mRNA level, the data on gender differences in renal cortical OAT1 in adult rats are inconsistent and vary from negative (20, 47) to marginal (males > females) (7) or clearly positive (males > females) and androgen dependent (8). The OAT3-related mRNA, however, exhibits strong gender differences (male > female) in the rat liver, but in the kidney these differences are either absent (20) or marginal in favor of males (7). The renal expression of mRNA for both transporters was lower in prepubertal than adult rats (7). These contradictory data prompted us to investigate in more detail the distribution and possible gender differences at the protein level of OAT1 and OAT3, as well as the sex hormones responsible for these differences along the rat nephron.
|
MATERIALS AND METHODS |
|---|
|
TOPABSTRACTMATERIALS AND METHODSRESULTSDISCUSSIONGRANTSREFERENCES |
|---|
Male and female Wistar rats aged 10–12 wk (adult) or 25 days (prepubertal) from the breeding colony at the Institute for Medical Research and Occupational Health in Zagreb were used. Animals were bred and maintained according to the Guide for Care and Use of Laboratory Animals (Washington, DC: National Academy Press, 1996). Before and during experiments, animals had free access to standard pelleted food and tap water. The studies were approved by the Institutional Ethics Committee.
Males were castrated by the scrotal route, whereas females were ovariectomized by the dorsal (lumbal) approach. The sham-operated animals underwent the same procedure, except that the respective organs were not removed. The operations were performed under proper anesthesia (Narketan, 80 mg/kg body mass/Xylapan, 12 mg/kg body mass ip). Eight days after surgery, the animals began treatment (sc) with either testosterone enanthate, estradiol dipropionate, or progesterone (2.5 mg·kg body mass–1·day–1 of each for 8 days). The hormones were injected in a sunflower oil solution, whereas control rats were treated with an equivalent amount of sunflower oil (0.5 ml·kg body mass–1·day–1).
Antibodies and Other Materials
Polyclonal (anti-peptide) rabbit anti-rat OAT1 antibodies used in these studies were from two sources, i.e., the commercial antibody (Ab-1; affinity-purified immune serum) and the respective peptide (OAT11-P; Alpha Diagnostic, San Antonio, TX), whereas the Ab-2 (crude immune serum) and the respective peptide were noncommercial (27, 44). The affinity-purified polyclonal (anti-peptide) rabbit anti-rat OAT3 antibody and its peptide were also noncommercial and have been described previously (21). The use of monoclonal anti-megalin holoprotein antibody (1H2) and of the affinity-purified polyclonal chicken-raised anti-V-ATPase 31-kDa subunit antibody has been described (1, 34). Secondary antibodies, which included the CY3-labeled (GARCY3) or alkaline phosphatase-labeled (GARAP) goat anti-rabbit IgG and fluorescein-labeled goat anti-mouse (GAMF) or donkey anti-chicken IgG (DACF), were purchased from Jackson ImmunoResearch Laboratories (West Grove, PA) and Kirkegaard and Perry (Gaithersburg, MD).
Narketan and Xylapan were purchased from Chassot (Bern, Switzerland). Oil solutions of testosterone enanthate, estradiol dipropionate, and progesterone were from RotexMedica (Trittau, Germany), Galenika (Zemun, Serbia), and Prolek (Belgrade, Serbia), respectively. The molecular mass standards, used in immunoblotting, were either from GIBCO BRL/Invitrogen (Carlsbad, CA) or from Bio-Rad (Hercules, CA). Various other chemicals in the study were the highest purity available and were purchased from either Sigma (St. Louis, MO) or Fisher Scientific (Pittsburgh, PA).
Tissue Fixation and Immunocytochemistry
In anesthetized rats the circulatory system was perfused via the left ventricle of the heart, first with aerated (95% O2-5% CO2) and temperature-equilibrated (37°C) PBS (in mM: 140 NaCl, 4 KCl, 2 K2HO4, pH 7.4) for 2–3 min, and then with 
180 ml PLP fixative (2% paraformaldehyde, 75 mM lysine, 10 mM sodium periodate) for 4–5 min (25). Kidneys were removed, sliced, and kept overnight in the same fixative at 4°C, followed by extensive washing in PBS and storage in PBS containing 0.02% NaN3 at 4°C until use.
To cut 4-µm frozen sections, tissue slices were infiltrated with 30% sucrose (in PBS) overnight, embedded in OCT medium (Tissue-Tek, Sakura, Japan), frozen at –25°C, and sectioned in a Leica CM 1850 cryostat (Leica Instruments, Nussloch, Germany). Sections were collected on Superfrost/Plus Microscope slides (Fischer Scientific), dried at room temperature for 2–3 h, and kept refrigerated until further use.
To perform double staining for OAT1 and megalin, the sections were rehydrated in PBS for 10 min and treated for 5 min with 1% SDS (in PBS) to expose cryptic antigenic sites (6). SDS was removed by an extensive washing with PBS. Nonspecific binding of antibodies was prevented by incubating the sections with 1% bovine serum albumin (in PBS) for 15 min, followed by one of the polyclonal anti-OAT1 antibodies (diluted with PBS: Ab-1, 100 µg/ml; Ab-2, 1:400) at 4°C overnight (for 12–14 h). Two washings followed with high-salt PBS (PBS containing 2.7% NaCl) and two washings with regular PBS (5 min each), incubation with the monoclonal anti-megalin antibody (1:100) at room temperature for 3 h, washing with high-salt and regular PBS (2 x 5 min each), incubation with GAMF (8 µg/ml in PBS) at room temperature for 60 min, washing with high-salt and regular PBS (2 x 5 min each), incubation with GARCY3 (1.6 µg/ml in PBS) at room temperature for 60 min, washing with high-salt and regular PBS (2 x 5 min each), and mounting in a fluorescence fading retardant (Vectashield, Vector Laboratories, Burlingame, CA).
The retrieval technique with SDS for showing OAT1 proved to give poor and inconsistent data for OAT3, and a harsher approach with several steps that included treatment with organic solutions, detergents, acidic buffers, and heating in a microwave oven, e.g., with steps usually employed in processing the paraffin sections, had to be used to expose OAT3. As found by extensive preliminary testing, a significant deviation from these steps yielded much weaker staining. Therefore, the dried tissue sections were incubated (steps) in xylol (30 min), isopropanol (5 min), 98% ethanol (5 min), 75% ethanol (5 min), 60% ethanol (5 min), water (5 min), and PBS (15 min), followed by four cycles (5 min each at 800 W) of heating in a microwave oven in 10 mM citrate buffer, pH 3, and cooling down to room temperature in the same buffer for 20 min. This followed (steps) washing in PBS (3 x 5 min), incubation in 0.5% Triton X-100 (in PBS; 15 min), 2% Triton X-100 (in PBS; 30 min), 1% bovine serum albumin (in PBS; 30 min), anti-OAT3 antibody (1:100 in PBS; at 4°C overnight), washing with 0.5% Triton X-100 (in PBS, 2 x 10 min), incubation in GARCY3 (1.6 µg/ml in PBS) at room temperature for 2 h, washing with 0.5% Triton X-100 (in PBS, 2 x 10 min) and PBS (1 x 10 min), and mounting in Vectashield.
To double stain OAT3 and V-ATPase, the sections were first processed and stained for OAT3 as described above and then incubated with the anti-V-ATPase 31-kDa subunit antibody (1:20) at room temperature for 3 h, washed, and incubated with DACF (8 µg/ml) at room temperature for 60 min, washed, and covered with Vectashield.
To test the staining specificity, the anti-OAT1 (Ab-1) and anti-OAT3 antibodies were blocked with the corresponding synthetic peptides (final concentration of the peptide: 0.25 mg/ml and 0.5 mg/ml, respectively) for 4 h at room temperature and then used in an immunofluorescence assay as described above.
The staining was examined and photographed with an Opton III RS fluorescence microscope (Opton Feintechnik, Oberkochen, Germany) using a Spot RT Slider camera and software (Diagnostic Instruments, Sterling Heights, MI). The photos were imported into Adobe Photoshop 6.0 and processed and labeled as required.
SDS-PAGE and Western Blotting
The rats were killed by decapitation. The kidneys were removed, and the cortex, outer stripe, inner stripe, and inner medulla (papilla) were dissected manually. Due to the small amount of the tissue, in some cases the inner stripe and inner medulla were pooled and processed as a single sample. The tissue collected from one rat was homogenized in 1–5 ml chilled buffer (in mM: 300 mannitol, 5 EGTA, 12 Tris·HCl, pH 7.4, 1 PMSF, 0.1 benzamidine, and 0.1 µg/ml antipain) with a Powergen 125 homogenizer (Fisher Scientific) at the maximal setting (1-min homogenization-1-min pause-1-min homogenization). The total cell membranes were isolated from these homogenates by first removing cell debris by centrifugation in a refrigerated high-speed centrifuge (Sorvall RC-5C, rotor SS34, Sorvall Instruments, Newtown, CT) at 5,000 g for 15 min. The pellets were discarded, and the supernatants were then centrifuged at 150,000 g for 1 h (ultracentrifuge Sorvall OTD-Combi, rotor T-875). The final pellets (total cell membranes) were resuspended in homogenizing buffer. BLM were isolated from the renal cortical homogenate by the Percoll density gradient centrifugation method of Scalera et al. (35). After dispersion of the membranes in an appropriate volume of homogenizing buffer and measurement of proteins by a dye-binding assay (4), all membrane preparations were stored at –70°C until further use in immunoblotting experiments.
Before electrophoresis, the membrane samples were thawed, mixed with sample buffer [final: 1% SDS, 12% vol/vol glycerol, 30 mM Tris·HCl, pH 6.8, with or without 5% 
-mercaptoethanol (-ME)], and denatured at either 37°C for 30 min or 65°C for 15 min, or 95°C for 5 min. Proteins (40–50 µg/lane and 50–100 µg/lane for BLM and total cell membrane preparations, respectively) were separated through 10% SDS-PAGE minigels using the Vertical Gel Electrophoresis System and then electrophoretically wet-transferred using a Mini Trans-Blot Electrophoretic Transfer Cell (Bio-Rad Laboratories) to an Immobilon membrane (Millipore, Bedford, MA). After transfer, the Immobilon membrane was briefly stained with Coomassie brilliant blue to check the efficiency of the transfer, destained, blocked in blotting buffer (5% nonfat dry milk, 0.15 M NaCl, 1% Triton X-100, 20 mM Tris·HCl, pH 7.4), and incubated at 4°C overnight (12–14 h) in the same buffer that contained one of the anti-OAT1 antibodies (Ab-1: 2.5 µg/ml; Ab-2: 1:1,000) or anti-OAT3 antibody (1:1,000), washed with four changes (15 min each) of blotting buffer, incubated for 60 min in the same buffer that contained 0.1 µg/ml GARAP, washed again, and stained for alkaline phosphatase activity using the 5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium method as an indicator.
To block the specific labeling of OAT3, the anti-OAT3 antibody was preincubated with the corresponding synthetic peptide (final concentration of the peptide: 0.5 mg/ml) for 4 h at room temperature and then used in an immunoblotting assay as described above.
The labeled protein bands were evaluated by densitometry. The density of each band was scanned (Ultroscan Laser Densitometer, Bromma, Sweden), and the integrated scan surface was used in further calculations. In preliminary experiments we evaluated band densities with different amounts of protein and found that these parameters correlated well with up to 50 µg protein/lane for OAT1 and 100 µg protein/lane for OAT3 (data not shown). The integrated surface of each scan was expressed in arbitrary units, relative to the medium band density (= 100 arbitrary units) in the corresponding control samples.
Presentation of Data
The immunocytochemical and numeric data represent findings in four animals in each experimental group. The numeric data, expressed as means ± SE, were statistically evaluated by using Student's t-test and ANOVA, Duncan's test, at the 5% level of significance.
|
RESULTS |
|---|
|
TOPABSTRACTMATERIALS AND METHODSRESULTSDISCUSSIONGRANTSREFERENCES |
|---|
Characterization of anti-OAT1 antibodies.
The commercial (Ab-1) and noncommercial (Ab-2) anti-OAT1 antibodies were first tested for efficiency and specificity of the staining by immunoblotting and immunocytochemistry. BLM were isolated from the kidney cortex of male rats, dissolved in sample buffer without or with 5% -ME, heated to 37, 65, or 95°C for 30, 15, or 5 min, respectively, and blotted with the antibodies. As shown in Fig. 1A, the membrane samples blotted with Ab-1 exhibited the best labeling of the OAT1-related protein band(s) after denaturation at 37°C for 30 min in the presence of -ME, indicating that the binding epitope was temperature sensitive. In addition to the protein band of 70–75 kDa, the antibody also labeled a band on top of the gel, reflecting the presence of partially nondenatured and/or polymeric forms of the protein that did not enter the gel. Ab-2 labeled the same protein bands, however, with much greater intensity. After various experimental manipulations and hormonal treatments, the density of the protein band on top of the gel was always weaker than that of the 70- to 75-kDa band (data not shown). The 70- to 75-kDa band, labeled with either antibody, was not compact but rather consisted of a strong middle band and two weaker side bands, which could represent the protein in different states of glycosylation.
|
The data obtained with both commmercial and noncommercial antibodies were entirely comparable (not shown). Taking into account optimal experimental conditions from the preceeding experiments, in further studies we used both antibodies for immunocytochemical and Ab-2 for immunoblotting.
Gender differences in expression of OAT1. To study gender differences in OAT1 expression, tissue cryosections from the kidney cortex and outer stripe of the adult male and female rats were double stained for OAT1 and megalin (Fig. 2). In the male kidney, OAT1 was brightly stained in the BLM of the S2 segments in the superficial cortex (Fig. 2A) and even more strongly in the S2 segments around the juxtamedullary glomeruli (Fig. 2C). In the outer stripe, the antibody weakly stained the BLM of many cells, and some cells in more proximal parts of the S3 had weak intracellular granular staining (Fig. 2E). The cells in this zone were stained with heterogeneous intensity, giving to this part of the S3 segment a mosaic appearance. Terminal parts of the S3 segments, as well as the loop of Henle, distal tubules, collecting ducts, and various structures around the tubules, were negative (not shown). In the female kidney, the pattern of OAT1 staining in proximal tubule segments in the superficial (Fig. 2B) and deep cortex (Fig. 2D) was similar to that in males, but the staining intensity was considerably weaker. In the outer stripe, the cells along the entire S3 segment were weakly stained basolaterally and (less) intracellularly (Fig. 2F) with an intensity similar to, or slightly stronger than, that in males.
|
|
|
30% (Fig. 5 and Table 1), whereas estradiol treatment of ovariectomized females further decreased the staining (data not shown) and downregulated (by 74%) the abundance of protein in total cell membrane vs. ovariectomized oil-treated females (Fig. 5 and Table 1).
|
|
Characterization of anti-OAT3 antibody.
By immunostaining of the male cortex, OAT3 was localized to the BLM of the S1 and S2 proximal tubule segments, distal tubules, and collecting ducts (Fig. 6A). The staining in all these localizations was abolished after preincubation of the antibody with the respective peptide (Fig. 6B). The immunoblotting was performed using the same conditions as for OAT1; in preliminary experiments the pattern of labeling of different OAT3-related bands was similar using the denaturing conditions without or with -ME and at different temperatures, but the respective protein bands were strongest after denaturation at 37°C for 30 min in the presence of -ME (data not shown). In immunoblots of the renal cortical BLM (Fig. 6C), the anti-OAT3 antibody labeled two distinct bands: the bottom band at 55–70 kDa was more complex and consisted of several smaller bands of different mobility, the broadest one being at 66 kDa; the top band at 116 kDa was more compact. These bands were clearly different from the 70- to 75-kDa band related to OAT1, indicating no cross-reactivity of the antibodies, and were completely blocked after preincubation of the antibody with the respective peptide (OAT3+PEP). Both bands were also detected in the total cell membrane preparations from the male kidney cortex (Fig. 6D; –PEPTIDE), except that the density of the 116-kDa band was variable in different membrane preparations. Therefore, in all further studies we used the more persistent 55- to 70-kDa band complex as a parameter for comparison of gender differences and different hormonal states and treatments. In total cell membranes from the inner stripe and inner medulla (Fig. 6D), we observed 1) a top band being much stronger than the bottom band and 2) a greater heterogeneity of the bottom band with a predominant mobility at 55–60 kDa. In the membranes from the outer stripe, only a weak top band was found. These bands were completely blocked by preincubating the antibody with the respective peptide (Fig. 6D; +PEPTIDE).
|
|
|
|
116 kDa and the 55- to 60-kDa complex, was strong, but gender differences in the density of either the top (not shown) or the bottom band complex (Table 2) were not observed. Further experiments were aimed to resolve which of the sex hormones caused the observed gender differences in the expression of cortical OAT3 in adult rats.
|
|
|
|
DISCUSSION |
|---|
|
TOPABSTRACTMATERIALS AND METHODSRESULTSDISCUSSIONGRANTSREFERENCES |
|---|
116 kDa; 2) OAT1 was largely stained in the BLM of the proximal tubule S2 segment, but the S3 segments also exhibited a limited staining both in the BLM and (less) intracellularly, whereas OAT3 was localized also basolaterally in the S1 and S2 proximal tubule segments (S3 was negative), TALH, distal tubule, and principal cells of the collecting duct; 3) gender differences in the expression of OAT1 in proximal convoluted tubules of adult rats were confirmed (males > females), whereas gender differences for OAT3 were clearly observed only in the cortical (proximal and distal) tubules; 4) in prepubertal rats, the expression of OAT1 and OAT3 in the cortical tubules was low and exhibited no gender differences; 5) castration in adult males caused a strong downregulation of both transporters in the cortical tubules, whereas ovariectomy in adult females led to the slight enhancement and no change in OAT1 and OAT3 expression, respectively, in cortical tubules; 6) in gonadectomized animals, the expression of both OAT1 and OAT3 in cortical tubules was strongly elevated by testosterone, whereas estradiol treatment caused an additional decrease; and 7) the expression of OAT1, but not of OAT3, in cortical tubules was upregulated by progesterone treatment in gonadectomized rats.
In immunoblots of the renal cortical BLM, the anti-OAT1 antibodies labeled a protein band of 70–75 kDa, the intensity of which was inversely related to the denaturing temperature, thus indicating that the antibody-binding epitope was temperature sensitive. In previous studies, OAT1 in the rat kidney was identified as either a 57 (11, 44)- or 77-kDa protein (27), whereas the human homolog was labeled as an 80- to 90-kDa protein band (13). At present, we have no explanation for the obvious discrepancies in the electrophoretic mobility of the OAT1 protein in previous and our studies. Rat OAT1 is a protein of 551 amino acid residues, with four potential N-glycosylation sites and a predicted molecular mass of the nonglycosylated form of 60 kDa (36, 43). Accordingly, human OAT1 decreased from 80–90 to 60 kDa after deglycosylation (13). Therefore, the size of the OAT1 protein band of the 70- to 75-kDa protein, as found in this study, is probably related to the glycosylated form of the protein. This possibility is also indicated by the pattern of the protein band, which was a complex of one strong middle band and two weaker side bands, which may represent different glycosylation states of the protein. In addition, in our blots the antibody also labeled a band on the gel top, which may reflect the presence of either a partially nondenatured protein and/or hitherto unrecognized polymeric forms of the protein. On the other side, OAT3 was previously labeled as a single band of 130 and 80 kDa in a crude plasma membane fraction from rat (21) and human (26) kidneys, respectively, whereas in this study the anti-OAT3 antibody labeled two major protein bands, one being more complex with multiple bands at 55–70 kDa, which was strongest in the membranes from the kidney cortex, where it peaked at 66 kDa, and another more compact band at 116 kDa, which was strongest in the membranes from the inner stripe and inner medulla. Both band complexes were strongly labeled in the BLM isolated from the kidney cortex, and both were completely blocked by the immunizing peptide in the membranes from various tissue zones, indicating specificity. As rat OAT3 is a polypeptide of 536 amino acid residues, with four putative N-glycosylation sites (22), our findings indicate that, under our experimental conditions, the complex band at 55–70 kDa may reflect monomeric proteins in various states of glycosylation, whereas the 116-kDa band may represent a dimeric form of the protein. The distribution of both protein complexes in the cell membranes from various tissue zones, as well as a generally similar pattern of their labeling in the cortical membranes from the intact, gonadectomized, and hormone-treated animals, indicates that both monomeric and dimeric forms exist in the same membrane preparations, except that the heterogeneously glycosylated monomeric form is more prevalent and consistent in the cortical membranes, where the dimeric form is present in an inconsistent abundance, whereas in membranes from the inner stripe and inner medulla the dimeric form prevails. A similar pattern of expression of both forms was also observed after heating of the membranes at different temperatures, except that the density of the final protein bands was strongest at 37°C (data not shown), which speaks against the temperature-dependent digestion of the membrane proteins as an explanation. The basis for the zone-related expression of monomers and putative dimers remains unexplained and was not further studied.
In accordance with recently published immunolocalization data in rat (21, 27, 44) and human kidney (26), our studies proved the presence of OAT1 in the BLM in cells along the proximal tubule, with predominant localization in the S2 segments. The S3 segments also exhibited a limited staining of OAT1 in both BLM and (less) intracellularly. This axial distribution of OAT1 along the rat renal proximal tubule fits previous functional data obtained with rabbit proximal tubules, showing highest PAH secretion in S2 segments (40, 41, 51), and suggests that OAT1 may have a similar distribution in the rabbit. The intracellular granular staining in some cells indicates a possible localization of the protein in a vesicle population that may be involved in the recycling of this transporter by means of endo- and exocytosis. Furthermore, previous studies identified OAT3 in the BLM of cortical proximal convoluted tubules in the human kidney and along the entire proximal tubule, TALH, connecting segment, and collecting duct in the rat kidney (21). The same distribution of OAT3 along the rat nephron was confirmed in our study. In addition, we showed that the basolateral localization along the collecting duct is restricted to the principal cells; the V-ATPase-positive A and B type intercalated cells were negative for OAT3. These data raise the question of a largely neglected function(s) and substrate specificity of OAT3 in the nephron segments that are distal from the proximal tubules; so far, the OAT-related transport of PAH and other organic anions has been characterized only in the proximal tubule segments.
Gender differences in the renal secretion of PAH and various other organic anions have been known for a long time (3, 5, 17, 19, 32). These differences in transport may reflect the differences in the respective transporter(s). Indeed, Cerrutti et al. (11) recently demonstrated by immunoblotting of isolated renal cortical BLM a 60% stronger OAT1-related protein band in male than in female kidney. We confirmed this finding for OAT1, however, with a much larger difference: in our hands, the density of the 70- to 75-kDa protein band in isolated renal cortical BLM from adult male rats was five times stronger than that in females. A similar difference in protein band density was retained in total cell membranes isolated from the renal cortex, allowing for a simpler membrane preparation procedure for studies of protein expression. The immunoblotting data were supported by immunocytochemistry; much higher staining intensity of OAT1 in the tubules of superficial and (even higher in) deep cortex in male than in female rats confirmed gender differences in OAT1 expression. Similar gender differences were observed for OAT3, however, only in the cortex. Compared with the respective data in females, the density of the OAT3-related 55- to 70-kDa protein band complex was stronger by 35–40% in the BLM and total cell membranes from the male cortex, and the staining intensity was visibly stronger in the male cortical tubules, whereas the immunostaining in other segments along the nephron and the abundance of OAT3 protein in isolated membranes from other tissue zones was rather heterogeneous, showing no clear-cut gender differences.
The gender differences in OAT1 and OAT3 existed in adult animals but not in prepubertal rats, which, in both sexes, exhibited a low abundance of these proteins in the cell membranes and a low intensity of the staining in the cortical tubules, thus explaining previously observed gender-independent and low PAH accumulation in renal cortical slices in young rats with immature kidney function (5, 27). The low abundance of renal OAT1 in prepubertal rats may be related to the lower expression level of the specific mRNA in these animals; Buist et al. (7) observed a gradual increase in mRNA expression from birth through day 35 thereafter. However, the findings by Nakajima et al. (27) were just the opposite and indicated a much higher expression of mRNA and OAT1 protein in very young than in adult rats. In addition, in one study mRNA for renal OAT3 already reached mature values 10–15 days after birth (7). These and other studies indicate that gender differences in cortical OAT1 and OAT3 proteins may not be a mere reflection of the expression of mRNA; clear gender differences in mRNA for OAT1 in the adult rat kidney were observed in one study (8), but not in a few others (7, 20, 47), and not for OAT3 (7, 20). However, our data with prepubertal (25 day) rats revealed abundances of the protein well below the adult values. This lack of correlation between OAT1 and OAT3 proteins and their mRNAs may be apparent, e.g., because different animal strains have been used in these studies. The possibility that mRNA-independent mechanisms affecting synthesis and/or degradation of OAT proteins may, in part, contribute to age and gender differences cannot be disregarded and requires additional experiments.
The absence of gender differences in the abundance of cortical OAT1 and OAT3 in prepubertal rats and their presence in adult rats indicated that the expression of these transporters depends on maturation and thus may be regulated by sex hormones. This possibility was supported by the findings of diminished PAH uptake in kidney cortical slices from castrated male rats and its stimulation after treatment of gonadectomized animals with testosterone, but not with estrogens (3, 5, 17, 19, 32). Our immunoblotting and immunocytochemical data corroborate previous PAH uptake studies in tissue slices in vitro. According to our data, both androgens and estrogens are responsible for the observed gender differences in OAT expression, however, by acting in opposite directions: after castration of adult males, cortical OAT1 and OAT3 expression was downregulated and was reversed by testosterone treatment, whereas treatment of castrated rats with estradiol caused additional downregulation. Furthermore, after ovariectomy of adult females, OAT1, but not OAT3, expression was slightly enhanced, whereas estrogen treatment in these rats further downregulated both proteins. In addition, progesterone treatment led to enhanced protein expression of OAT1 in castrated males. At present, it is unclear whether these effects of sex steroids are at the genomic and/or nongenomic levels, mediated by specific steroid receptors. At the message or protein level, steroid receptors for androgens, estrogen, and progesterone have been reported in animal and human kidneys (9, 15, 23, 28 and references therein; 49, 52). In one report, estrogen receptors have been localized to the proximal tubule of the Rhesus monkey (14), but a detailed immunolocalization of various sex steroid receptors in rat and human kidneys, which would allow correlation with our OAT data in male and female rat kidneys, has to our knowledge not been reported. Our findings nevertheless indicate the possibility that various physiological states, associated with variable levels of endogenous sex hormones, such as sexual cycle, pregnancy and menopause in women, and aging in both sexes, may influence renal organic anion secretion via hormone-dependent expression of the two major transporters, OAT1 and OAT3, that are located in the BLM of proximal (both transporters) and distal (OAT3) tubules. Further examples of sex hormone-dependent transporter mRNA expression are rat renal OAT2 (females > males; 7), organic cation transporter OCT2 (males > females; 47), and Oatp1 (males > females; 18). Thereby, gender differences may have profound effects, at least in the rat, on renal drug clearance mediated by OATs, OCTs, and Oatp1.
In conclusion, our data indicate that gender differences in OAT1 and OAT3 in rat renal cortical tubules appear after puberty and are determined by both a stimulatory effect of androgens (and progesterone in case of OAT1) and an inhibitory effect of estrogens. The presence of OAT3 in the distal parts of the nephron, including the TALH and collecting duct, indicates that the distal parts of the nephron may also contribute to the organic anion secretion, however, with an unknown efficiency and substrate specificity. The possible impact of these gender differences and transporter localizations on renal drug excretion and pharmacokinetics of anionic drugs may be of clinical importance and remains to be determined.
|
GRANTS |
|---|
|
TOPABSTRACTMATERIALS AND METHODSRESULTSDISCUSSIONGRANTSREFERENCES |
|---|
) and by a collaborative Croatian-German grant (I. Saboli and G. Burckhardt).
|
ACKNOWLEDGMENTS |
|---|
ak for technical assistance. |
FOOTNOTES |
|---|
, Unit of Molecular Toxicology, Institute for Medical Research and Occupational Health, Ksaverska cesta 2, PO Box 291, HR-10001 Zagreb, Croatia (E-mail: sabolic{at}imi.hr).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
|
REFERENCES |
|---|
|
TOPABSTRACTMATERIALS AND METHODSRESULTSDISCUSSIONGRANTSREFERENCES |
|---|
2-m receptor-associated protein (2-MRAP) and its binding sites in kidney: distribution of endogenous 2-MRAP is modified by tissue processing. Eur J Cell Biol 61: 139–149, 1993.
I, Herak-Kramberger CM, Breton S, and Brown D. Na/K-ATPase in intercalated cells along the rat nephron revealed by antigen retrieval. J Am Soc Nephrol 10: 913–922, 1999.
I, Ljubojevi M, Herak-Kramberger CM, and Brown D. Cd-MT causes endocytosis of brush-border transporters in rat renal proximal tubules. Am J Physiol Renal Physiol 283: F1389–F1402, 2002.
-KG with basolateral organic anion transporter in isolated rabbit renal S3 proximal tubules. Am J Physiol Renal Fluid Electrolyte Physiol 268: F1109–F1116, 1995.
This article has been cited by other articles:
|
|
 |
|
  N. Perrottet, C. Csajka, M. Pascual, O. Manuel, F. Lamoth, P. Meylan, J. D. Aubert, J. P. Venetz, P. Soccal, L. A. Decosterd, et al. Population Pharmacokinetics of Ganciclovir in Solid-Organ Transplant Recipients Receiving Oral Valganciclovir Antimicrob. Agents Chemother., July 1, 2009; 53(7): 3017 - 3023. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. B. Buckley and C. D. Klaassen Mechanism of Gender-Divergent UDP-Glucuronosyltransferase mRNA Expression in Mouse Liver and Kidney Drug Metab. Dispos., April 1, 2009; 37(4): 834 - 840. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Kwon, W.-W. Wang, and S. Miller Renal organic anion transporter 1 is maldistributed and diminishes in proximal tubule cells but increases in vasculature after ischemia and reperfusion Am J Physiol Renal Physiol, December 1, 2008; 295(6): F1807 - F1816. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Vallon, S. A. Eraly, W. R. Wikoff, T. Rieg, G. Kaler, D. M. Truong, S.-Y. Ahn, N. R. Mahapatra, S. K. Mahata, J. A. Gangoiti, et al. Organic Anion Transporter 3 Contributes to the Regulation of Blood Pressure J. Am. Soc. Nephrol., September 1, 2008; 19(9): 1732 - 1740. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Balen, M. Ljubojevic, D. Breljak, H. Brzica, V. Zlender, H. Koepsell, and I. Sabolic Revised immunolocalization of the Na+-D-glucose cotransporter SGLT1 in rat organs with an improved antibody Am J Physiol Cell Physiol, August 1, 2008; 295(2): C475 - C489. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. VanWert, C. Srimaroeng, and D. H. Sweet Organic Anion Transporter 3 (Oat3/Slc22a8) Interacts with Carboxyfluoroquinolones, and Deletion Increases Systemic Exposure to Ciprofloxacin Mol. Pharmacol., July 1, 2008; 74(1): 122 - 131. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Vallon, T. Rieg, S. Y. Ahn, W. Wu, S. A. Eraly, and S. K. Nigam Overlapping in vitro and in vivo specificities of the organic anion transporters OAT1 and OAT3 for loop and thiazide diuretics Am J Physiol Renal Physiol, April 1, 2008; 294(4): F867 - F873. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Eraly, V. Vallon, T. Rieg, J. A. Gangoiti, W. R. Wikoff, G. Siuzdak, B. A. Barshop, and S. K. Nigam Multiple organic anion transporters contribute to net renal excretion of uric acid Physiol Genomics, April 1, 2008; 33(2): 180 - 192. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Kwon, S.-M. Hong, and K. Blouch Alteration in Renal Organic Anion Transporter 1 After Ischemia/Reperfusion in Cadaveric Renal Allografts J. Histochem. Cytochem., June 1, 2007; 55(6): 575 - 584. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Schneider, C. Sauvant, B. Betz, M. Otremba, D. Fischer, H. Holzinger, C. Wanner, J. Galle, and M. Gekle Downregulation of organic anion transporters OAT1 and OAT3 correlates with impaired secretion of para-aminohippurate after ischemic acute renal failure in rats Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1599 - F1605. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ljubojevic, D. Balen, D. Breljak, M. Kusan, N. Anzai, A. Bahn, G. Burckhardt, and I. Sabolic Renal expression of organic anion transporter OAT2 in rats and mice is regulated by sex hormones Am J Physiol Renal Physiol, January 1, 2007; 292(1): F361 - F372. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Asif, M. Ljubojevic, I. Sabolic, V. Shnitsar, M. Metten, N. Anzai, G. A. Muller, G. Burckhardt, and Y. Hagos Regulation of steroid hormone biosynthesis enzymes and organic anion transporters by forskolin and DHEA-S treatment in adrenocortical cells Am J Physiol Endocrinol Metab, December 1, 2006; 291(6): E1351 - E1359. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Bakhiya, M. Stephani, A. Bahn, B. Ugele, A. Seidel, G. Burckhardt, and H. Glatt Uptake of Chemically Reactive, DNA-Damaging Sulfuric Acid Esters into Renal Cells by Human Organic Anion Transporters J. Am. Soc. Nephrol., May 1, 2006; 17(5): 1414 - 1421. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Sabolic, M. Skarica, V. Gorboulev, M. Ljubojevic, D. Balen, C. M. Herak-Kramberger, and H. Koepsell Rat renal glucose transporter SGLT1 exhibits zonal distribution and androgen-dependent gender differences Am J Physiol Renal Physiol, April 1, 2006; 290(4): F913 - F926. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Sekine, H. Miyazaki, and H. Endou Molecular physiology of renal organic anion transporters Am J Physiol Renal Physiol, February 1, 2006; 290(2): F251 - F261. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Sauvant, H. Holzinger, and M. Gekle Prostaglandin E2 Inhibits Its Own Renal Transport by Downregulation of Organic Anion Transporters rOAT1 and rOAT3 J. Am. Soc. Nephrol., January 1, 2006; 17(1): 46 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bahn, M. Ljubojevic, H. Lorenz, C. Schultz, E. Ghebremedhin, B. Ugele, I. Sabolic, G. Burckhardt, and Y. Hagos Murine renal organic anion transporters mOAT1 and mOAT3 facilitate the transport of neuroactive tryptophan metabolites Am J Physiol Cell Physiol, November 1, 2005; 289(5): C1075 - C1084. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Wood, R. Cousins, D. Zhang, and M. Keller-Wood Ontogeny of Expression of Organic Anion Transporters 1 and 3 in Ovine Fetal and Neonatal Kidney Experimental Biology and Medicine, October 1, 2005; 230(9): 668 - 673. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
